Author response: A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency

MLA

Manabu Aoki, et al. Author Response: A Novel Central Nervous System-Penetrating Protease Inhibitor Overcomes Human Immunodeficiency Virus 1 Resistance with Unprecedented AM to PM Potency. Sept. 2017. EBSCOhost, https://doi.org/10.7554/elife.28020.020.

APA

Manabu Aoki, Hironori Hayashi, Kalapala Venkateswara Rao, Debananda Das, Nobuyo Higashi-Kuwata, Haydar Bulut, Hiromi Aoki-Ogata, Yuki Takamatsu, Ravikiran S Yedidi, David A Davis, Shin-ichiro Hattori, Noriko Nishida, Kazuya Hasegawa, Nobutoki Takamune, Prasanth R Nyalapatla, Heather L Osswald, Hirofumi Jono, Hideyuki Saito, Robert Yarchoan, … Hiroaki Mitsuya. (2017). Author response: A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency. https://doi.org/10.7554/elife.28020.020

Chicago

Manabu Aoki, Hironori Hayashi, Kalapala Venkateswara Rao, Debananda Das, Nobuyo Higashi-Kuwata, Haydar Bulut, Hiromi Aoki-Ogata, et al. 2017. “Author Response: A Novel Central Nervous System-Penetrating Protease Inhibitor Overcomes Human Immunodeficiency Virus 1 Resistance with Unprecedented AM to PM Potency,” September. doi:10.7554/elife.28020.020.